Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells

Thomas J. Abbruscato, Steve P. Lopez, Karen S. Mark, Brian T. Hawkins, Thomas P Davis

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

The blood-brain barrier (BBB) adapts to a variety of pathological processes. Little is known about the effects of nicotine exposure on BBB function and the ability to adapt to stroke conditions. We have demonstrated, using a well-characterized in vitro BBB model, bovine brain microvessel endothelial cells (BBMEC) model, that nicotine and its major metabolite, cotinine, modulate BBB integrity by opening the paracellular route of solute entry into the brain. Additionally, nicotine and cotinine together increase the permeability change observed after 6 h of hypoxia/aglycemia, an in vitro model of stroke. This has important implications for how the BBB initially adapts to stroke in an environment that is previousely exposed to nicotine. Nicotine and cotinine exposure also resulted in reduced ZO-1 immunoreactivity (tight junctional protein) that occurred in a time-dependent manner. Interestingly, attenuation of bovine brain microvessel endothelial cell (BBMEC) ZO-1 protein expression was reversed using 10 nM BGT, an α7 nicotinic acetycholine receptor (nAChR) antagonist, suggesting that the effects of nicotine on BBMEC protein expression of ZO-1 protein are mediated by nAChR expressed on brain endothelial cells. In addition to α7, we found that BBMEC also contain positive immunoreactivity for the α3, α5, β2, β3 nAChR subunit. Both α7 and β2 nAChR subunit protein levels decreased with prior nicotine and cotinine exposure. These data provide evidence that nicotine and cotinine alter BBB permeability and tight junctional protein expression of ZO-1, thereby altering the BBB response to stroke conditions. These changes in brain endothelial cell paracellular permeability are believed to be associated with nicotine binding to nAChRs present at the BBB.

Original languageEnglish (US)
Pages (from-to)2525-2538
Number of pages14
JournalJournal of Pharmaceutical Sciences
Volume91
Issue number12
DOIs
StatePublished - Dec 2002

Fingerprint

Cotinine
Endothelial cells
Nicotinic Receptors
Capillary Permeability
Nicotine
Blood-Brain Barrier
Brain
Endothelial Cells
Microvessels
Proteins
Stroke
Permeability
Brain models
Protein Subunits
Pathologic Processes
Metabolites

Keywords

  • Blood-brain barrier
  • Cotinine
  • Endothelial cell
  • Nicotine
  • Tight junction
  • ZO-1

ASJC Scopus subject areas

  • Molecular Medicine
  • Chemistry(all)
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Pharmacology

Cite this

Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. / Abbruscato, Thomas J.; Lopez, Steve P.; Mark, Karen S.; Hawkins, Brian T.; Davis, Thomas P.

In: Journal of Pharmaceutical Sciences, Vol. 91, No. 12, 12.2002, p. 2525-2538.

Research output: Contribution to journalArticle

@article{bf83aa466e594a90bff040cee97b671f,
title = "Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells",
abstract = "The blood-brain barrier (BBB) adapts to a variety of pathological processes. Little is known about the effects of nicotine exposure on BBB function and the ability to adapt to stroke conditions. We have demonstrated, using a well-characterized in vitro BBB model, bovine brain microvessel endothelial cells (BBMEC) model, that nicotine and its major metabolite, cotinine, modulate BBB integrity by opening the paracellular route of solute entry into the brain. Additionally, nicotine and cotinine together increase the permeability change observed after 6 h of hypoxia/aglycemia, an in vitro model of stroke. This has important implications for how the BBB initially adapts to stroke in an environment that is previousely exposed to nicotine. Nicotine and cotinine exposure also resulted in reduced ZO-1 immunoreactivity (tight junctional protein) that occurred in a time-dependent manner. Interestingly, attenuation of bovine brain microvessel endothelial cell (BBMEC) ZO-1 protein expression was reversed using 10 nM BGT, an α7 nicotinic acetycholine receptor (nAChR) antagonist, suggesting that the effects of nicotine on BBMEC protein expression of ZO-1 protein are mediated by nAChR expressed on brain endothelial cells. In addition to α7, we found that BBMEC also contain positive immunoreactivity for the α3, α5, β2, β3 nAChR subunit. Both α7 and β2 nAChR subunit protein levels decreased with prior nicotine and cotinine exposure. These data provide evidence that nicotine and cotinine alter BBB permeability and tight junctional protein expression of ZO-1, thereby altering the BBB response to stroke conditions. These changes in brain endothelial cell paracellular permeability are believed to be associated with nicotine binding to nAChRs present at the BBB.",
keywords = "Blood-brain barrier, Cotinine, Endothelial cell, Nicotine, Tight junction, ZO-1",
author = "Abbruscato, {Thomas J.} and Lopez, {Steve P.} and Mark, {Karen S.} and Hawkins, {Brian T.} and Davis, {Thomas P}",
year = "2002",
month = "12",
doi = "10.1002/jps.10256",
language = "English (US)",
volume = "91",
pages = "2525--2538",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells

AU - Abbruscato, Thomas J.

AU - Lopez, Steve P.

AU - Mark, Karen S.

AU - Hawkins, Brian T.

AU - Davis, Thomas P

PY - 2002/12

Y1 - 2002/12

N2 - The blood-brain barrier (BBB) adapts to a variety of pathological processes. Little is known about the effects of nicotine exposure on BBB function and the ability to adapt to stroke conditions. We have demonstrated, using a well-characterized in vitro BBB model, bovine brain microvessel endothelial cells (BBMEC) model, that nicotine and its major metabolite, cotinine, modulate BBB integrity by opening the paracellular route of solute entry into the brain. Additionally, nicotine and cotinine together increase the permeability change observed after 6 h of hypoxia/aglycemia, an in vitro model of stroke. This has important implications for how the BBB initially adapts to stroke in an environment that is previousely exposed to nicotine. Nicotine and cotinine exposure also resulted in reduced ZO-1 immunoreactivity (tight junctional protein) that occurred in a time-dependent manner. Interestingly, attenuation of bovine brain microvessel endothelial cell (BBMEC) ZO-1 protein expression was reversed using 10 nM BGT, an α7 nicotinic acetycholine receptor (nAChR) antagonist, suggesting that the effects of nicotine on BBMEC protein expression of ZO-1 protein are mediated by nAChR expressed on brain endothelial cells. In addition to α7, we found that BBMEC also contain positive immunoreactivity for the α3, α5, β2, β3 nAChR subunit. Both α7 and β2 nAChR subunit protein levels decreased with prior nicotine and cotinine exposure. These data provide evidence that nicotine and cotinine alter BBB permeability and tight junctional protein expression of ZO-1, thereby altering the BBB response to stroke conditions. These changes in brain endothelial cell paracellular permeability are believed to be associated with nicotine binding to nAChRs present at the BBB.

AB - The blood-brain barrier (BBB) adapts to a variety of pathological processes. Little is known about the effects of nicotine exposure on BBB function and the ability to adapt to stroke conditions. We have demonstrated, using a well-characterized in vitro BBB model, bovine brain microvessel endothelial cells (BBMEC) model, that nicotine and its major metabolite, cotinine, modulate BBB integrity by opening the paracellular route of solute entry into the brain. Additionally, nicotine and cotinine together increase the permeability change observed after 6 h of hypoxia/aglycemia, an in vitro model of stroke. This has important implications for how the BBB initially adapts to stroke in an environment that is previousely exposed to nicotine. Nicotine and cotinine exposure also resulted in reduced ZO-1 immunoreactivity (tight junctional protein) that occurred in a time-dependent manner. Interestingly, attenuation of bovine brain microvessel endothelial cell (BBMEC) ZO-1 protein expression was reversed using 10 nM BGT, an α7 nicotinic acetycholine receptor (nAChR) antagonist, suggesting that the effects of nicotine on BBMEC protein expression of ZO-1 protein are mediated by nAChR expressed on brain endothelial cells. In addition to α7, we found that BBMEC also contain positive immunoreactivity for the α3, α5, β2, β3 nAChR subunit. Both α7 and β2 nAChR subunit protein levels decreased with prior nicotine and cotinine exposure. These data provide evidence that nicotine and cotinine alter BBB permeability and tight junctional protein expression of ZO-1, thereby altering the BBB response to stroke conditions. These changes in brain endothelial cell paracellular permeability are believed to be associated with nicotine binding to nAChRs present at the BBB.

KW - Blood-brain barrier

KW - Cotinine

KW - Endothelial cell

KW - Nicotine

KW - Tight junction

KW - ZO-1

UR - http://www.scopus.com/inward/record.url?scp=0036891988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036891988&partnerID=8YFLogxK

U2 - 10.1002/jps.10256

DO - 10.1002/jps.10256

M3 - Article

C2 - 12434396

AN - SCOPUS:0036891988

VL - 91

SP - 2525

EP - 2538

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 12

ER -